dronedarone has been researched along with Cardiac Failure in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (12.50) | 29.6817 |
2010's | 25 (78.13) | 24.3611 |
2020's | 3 (9.38) | 2.80 |
Authors | Studies |
---|---|
Albuquerque, APA; Anker, SD; Braceras, R; Butler, J; Camm, AJ; Crijns, HJGM; Hohnloser, SH; Piccini, JP; Stewart, J; Vaduganathan, M; Wieloch, M | 1 |
Boriani, G; Imberti, JF; Vitolo, M | 1 |
Deering, TF; Reiffel, JA; Solomon, AJ; Tamirisa, KP | 1 |
Ariano, C; De Vecchis, R | 1 |
Bergfeldt, L; Blomström-Lundqvist, C; Boriani, G; Botto, GL; Camm, AJ; Capucci, A; Goette, A; Hohnloser, SH; Israel, CW; Lozano, IF; Merino, JL | 1 |
Caubel, P; Dai, W; Juhaeri, J; Koren, A; Tcherny-Lessenot, S; Thammakhoune, J; Wu, C; Wu, J | 1 |
Friberg, L | 1 |
Connolly, SJ; Halperin, JL; Hohnloser, SH; John Camm, A; Radzik, D | 1 |
Kowey, PR; Naccarelli, GV | 1 |
Camm, AJ; Connolly, SJ; Gao, P; Halperin, JL; Hohnloser, SH; Radzik, D | 1 |
Amlie, J; Carlsen, J; Crijns, H; Gøtzsche, O; Køber, L; Lévy, S; McMurray, JJ; Torp-Pedersen, C | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Cullington, D | 1 |
Preobrazhenskiĭ, DV | 1 |
Christiansen, CB; Køber, L; Torp-Pedersen, C | 1 |
Garg, RK; Hundal, M | 1 |
Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M | 1 |
Coons, JC; Plauger, KM; Seybert, AL; Sokos, GG | 1 |
Ghali, JK; Giles, T; Levine, TB; Radzik, D | 1 |
Banchs, JE; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, E; Samii, S; Wolbrette, DL | 1 |
Brachmann, J; Ritscher, G; Simon Demel, K; Simon, H; Turschner, O | 1 |
Becker, R; Katus, HA; Schweizer, PA; Thomas, D | 1 |
Naccarelli, GV | 1 |
Mourouzis, I; Pantos, C | 1 |
Afzal, R; Alings, M; Amerena, J; Atar, D; Avezum, Á; Baret-Cormel, L; Blomström, P; Borggrefe, M; Budaj, A; Camm, AJ; Chen, SA; Ching, CK; Chrolavicius, S; Commerford, P; Connolly, SJ; Dans, A; Davy, JM; Delacrétaz, E; Di Pasquale, G; Diaz, R; Dorian, P; Flaker, G; Golitsyn, S; Gonzalez-Hermosillo, A; Granger, CB; Halperin, JL; Heidbüchel, H; Hohnloser, SH; Joyner, C; Kautzner, J; Kim, JS; Lanas, F; Lewis, BS; Merino, JL; Morillo, C; Murin, J; Narasimhan, C; Paolasso, E; Parkhomenko, A; Peters, NS; Sim, KH; Staiger, C; Stiles, MK; Tanomsup, S; Toivonen, L; Tomcsányi, J; Torp-Pedersen, C; Tse, HF; Vardas, P; Vinereanu, D; Weinling, E; Xavier, D; Yusuf, S; Zhu, J; Zhu, JR | 1 |
Fischer, GW; Trigo, P | 1 |
Aikat, S; Chatterjee, S; Ghosh, J; Lichstein, E; Mukherjee, D | 1 |
Eckardt, L; Vogler, J | 1 |
Saklani, P; Skanes, A | 1 |
Adlan, AM; Lip, GY | 1 |
Aliot, E; Capucci, A; Connolly, S; Crijns, H; Hohnloser, S; Immordino, L; Kowey, P; Radzik, D; Roy, D | 1 |
Ezekowitz, MD | 1 |
14 review(s) available for dronedarone and Cardiac Failure
Article | Year |
---|---|
Effects of dronedarone on all-cause mortality and on cardiovascular events in patients treated for atrial fibrillation: a meta-analysis of RCTs.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Heart Failure; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Time Factors | 2019 |
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Antithrombins; Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Dabigatran; Digoxin; Dronedarone; Drug Interactions; Factor Xa Inhibitors; Heart Failure; Hospitalization; Humans; Mortality; Pyridines; Randomized Controlled Trials as Topic; Thiazoles | 2019 |
An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Heart Failure; Hospitalization; Humans; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2014 |
The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Half-Life; Heart Failure; Hospitalization; Humans; Randomized Controlled Trials as Topic; Risk; Secondary Prevention | 2014 |
Efficacy and safety of dronedarone: a review of randomized trials.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Heart Failure; Heart Rate; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2010 |
Dronedarone--a new alternative for management of atrial fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Dronedarone; Heart Failure; Heart Rate; Humans; Patents as Topic; Secondary Prevention | 2010 |
A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Dronedarone; Heart Failure; Humans; Risk Factors; Secondary Prevention | 2010 |
[New developments in the antiarrhythmic therapy of atrial fibrillation].
Topics: Acetanilides; Aged; Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug-Related Side Effects and Adverse Reactions; Drugs, Investigational; Electrocardiography; Heart Atria; Heart Failure; Heart Ventricles; Humans; Piperazines; Potassium Channels; Pyrrolidines; Ranolazine; Sodium Channels; Stroke | 2010 |
Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Heart Failure; Hospitalization; Humans | 2011 |
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Dronedarone; Female; Heart Failure; Humans; Liver; Male; Multicenter Studies as Topic | 2012 |
Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Heart Failure; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Pharmacology of myocardial calcium-handling.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Cardiomegaly; Cardiotonic Agents; Digitalis Glycosides; Dronedarone; Electrocardiography; Heart Failure; Humans; Ion Channels; Myocardial Contraction; Piperazines; Ranolazine; Signal Transduction; Tachycardia | 2012 |
Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left | 2012 |
Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Dronedarone; Heart Failure; Heart Rate; Humans; Risk Assessment | 2013 |
8 trial(s) available for dronedarone and Cardiac Failure
Article | Year |
---|---|
Interaction between digoxin and dronedarone in the PALLAS trial.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiotonic Agents; Cause of Death; Digoxin; Double-Blind Method; Dronedarone; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Proportional Hazards Models; Risk Factors; Time Factors; Treatment Outcome | 2014 |
Increased mortality after dronedarone therapy for severe heart failure.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Diseases; Cause of Death; Double-Blind Method; Dronedarone; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Treatment Failure; Ventricular Dysfunction, Left | 2008 |
[Efficacy of dronedarone in cardiac failure due to severe left ventricular systolic dysfunction. Results of the ANDROMEDA].
Topics: Amiodarone; Dose-Response Relationship, Drug; Double-Blind Method; Dronedarone; Follow-Up Studies; Heart Failure; Humans; Prospective Studies; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2008 |
Dronedarone in patients with congestive heart failure: insights from ATHENA.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Creatinine; Dronedarone; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure.
Topics: Amiodarone; Dose-Response Relationship, Drug; Double-Blind Method; Dronedarone; Exercise; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Placebos; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Post-ATHENA and beyond.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Heart Failure; Heart Ventricles; Hospitalization; Humans; Risk Assessment; Secondary Prevention; Treatment Outcome | 2011 |
Comment: worsening heart failure in the setting of dronedarone initiation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Heart Failure; Humans; Male; Middle Aged; Treatment Failure | 2011 |
Dronedarone in high-risk permanent atrial fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Chronic Disease; Digoxin; Double-Blind Method; Dronedarone; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Risk Factors; Stroke | 2011 |
10 other study(ies) available for dronedarone and Cardiac Failure
Article | Year |
---|---|
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Dronedarone; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2022 |
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey?
Topics: Atrial Fibrillation; Dronedarone; Heart Failure; Humans; Stroke Volume | 2022 |
Chapter 2: Rate Versus Rhythm Control.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Dronedarone; Heart Failure; Heart Rate; Hospitalization; Humans | 2023 |
Assessment of dronedarone utilization using US claims databases.
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Contraindications; Creatinine; Databases, Factual; Dronedarone; Drug Interactions; Drug Prescriptions; Drug Utilization Review; Female; Heart Failure; Hospitalization; Humans; Insurance Claim Review; Middle Aged; Retrospective Studies; Young Adult | 2014 |
Safety of dronedarone in routine clinical care.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Heart Failure; Humans; Liver Failure; Male | 2014 |
Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiotonic Agents; Clinical Trials as Topic; Dronedarone; Heart Failure; Humans | 2008 |
Worsening heart failure in the setting of dronedarone initiation.
Topics: Acute Kidney Injury; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Progression; Dronedarone; Heart Failure; Humans; Liver Failure, Acute; Male; Middle Aged | 2010 |
Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Dronedarone; European Union; Heart Failure; Heart Rate; Humans | 2010 |
Effects of dronedarone started rapidly after amiodarone discontinuation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Dronedarone; Drug Substitution; Female; Half-Life; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Patient Selection; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |
Maintaining sinus rhythm--making treatment better than the disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Heart Failure; Humans; Secondary Prevention | 2007 |